The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Prevalence of Vitamin D Insufficiency in Patients With Parkinson Disease and Alzheimer Disease
Open accessAbstract
BACKGROUND: A role for vitamin D deficiency in Parkinson disease (PD) has recently been proposed. OBJECTIVE: To compare the prevalence of vitamin D deficiency in a research database cohort of patients with PD with the prevalence in age-matched healthy controls and patients with Alzheimer disease (AD). DESIGN: Survey study and blinded comparison of plasma 25-hydroxyvitamin D (25[OH]D) concentrations of stored samples in a clinical research database at Emory University School of Medicine. SETTING: Referral center (PD and AD patients), primary care clinics, and community setting (controls). PARTICIPANTS: Participants were recruited into the study between May 1992 and March 2007. Every fifth consecutively enrolled PD patient was selected from the clinical research database. Unrelated AD (n = 97) and control (n = 99) participants were randomly selected from the database after matching for age, sex, race, APOE genotype, and geographic location. MAIN OUTCOME MEASURES: Prevalence of suboptimal vitamin D and mean 25(OH)D concentrations. RESULTS: Significantly more patients with PD (55%) had insufficient vitamin D than did controls (36%) or patients with AD (41%; P = .02, chi(2)test). The mean (SD) 25(OH)D concentration in the PD cohort was significantly lower than in the AD and control cohorts (31.9 [13.6] ng/mL vs 34.8 [15.4] ng/mL and 37.0 [14.5] ng/mL, respectively; P = .03). CONCLUSIONS: This report of 25(OH)D concentrations in a predominantly white PD cohort demonstrates a significantly higher prevalence of hypovitaminosis in PD vs both healthy controls and patients with AD. These data support a possible role of vitamin D insufficiency in PD. Further studies are needed to determine the factors contributing to these differences and elucidate the potential role of vitamin D in pathogenesis and clinical course of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease [RETRACTED]
Sato, Y., Kikuyama, M., & Oizumi, K. (1997) · Neurology · doi:10.1212/wnl.49.5.1273 · Cited by 221
RetractedSatō, Y., Asoh, T., & Oizumi, K. (1998) · Bone · doi:10.1016/s8756-3282(98)00134-3 · Cited by 140
RetractedRetracted: Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients
Satō, Y., Honda, Y., Iwamoto, J., Kanoko, T., & Satoh, K. (2005) · Movement Disorders · doi:10.1002/mds.20658 · Cited by 79
RetractedSato, Y., Iwamoto, J., Kanoko, T., & Satoh, K. (2006) · Movement Disorders · doi:10.1002/mds.20825 · Cited by 56
RetractedMcKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis
Holick, M. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.3.362 · Cited by 1,665
Distribution of the vitamin D receptor and 1α-hydroxylase in human brain
Eyles, D. W., Smith, S., Kinobe, R., Hewison, M., & McGrath, J. J. (2005) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.08.006 · Cited by 1,444
The Role of Vitamin D in Cancer Prevention
Garland, C. F., Garland, F. C., Gorham, E. D., Lipkin, M., Newmark, H., Mohr, S. B., & Holick, M. F. (2006) · American Journal of Public Health · doi:10.2105/ajph.2004.045260 · Cited by 1,031
Noncalcemic Actions of Vitamin D Receptor Ligands
Nagpal, S., Na, S., & Rathnachalam, R. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0002 · Cited by 961
Bischoff-Ferrari, H. A., Dietrich, T., Orav, E. J., Hu, F. B., Zhang, Y., Karlson, E. W., & Dawson-Hughes, B. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.752 · Cited by 930
New clues about vitamin D functions in the nervous system
Garcion, E., Wion-Barbot, N., Montero-Menei, C. N., Berger, F., & Wion, D. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00547-1 · Cited by 904
Optimal Vitamin D Status for Colorectal Cancer Prevention
Gorham, E. D., Garland, C. F., Garland, F. C., Grant, W. B., Mohr, S. B., Lipkin, M., Newmark, H. L., Giovannucci, E., Wei, M., & Holick, M. F. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.11.004 · Cited by 535
Vitamin D and disease prevention with special reference to cardiovascular disease
Zittermann, A. (2006) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2006.02.001 · Cited by 447
Li, H., Stampfer, M. J., Hollis, J. B. W., Mucci, L. A., Gaziano, J. M., Hunter, D., Giovannucci, E. L., & Ma, J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040103 · Cited by 290
Survival and cause of death in Alzheimer's disease and multi-infarct dementia
Mölsä, P. K., Marttila, R. J., & Rinne, U. K. (1986) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1986.tb04634.x · Cited by 230
Vitamin D and Parkinson's disease—A hypothesis
Newmark, H. L., & Newmark, J. (2007) · Movement Disorders · doi:10.1002/mds.21317 · Cited by 183
Estimated life expectancy of Parkinson's patients compared with the UK population
Ishihara, L. S., Cheesbrough, A., Brayne, C., & Schrag, A. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.100107 · Cited by 173
Relative contributions of diet and sunlight to vitamin D state in the elderly.
Lawson, D. E., Paul, A. A., Black, A. E., Cole, T. J., Mandal, A. R., & Davie, M. (1979) · BMJ · doi:10.1136/bmj.2.6185.303 · Cited by 167
Gerdes, L. U. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.094 · Cited by 101
Chronic vitamin D deficiency in the weanling rat alters catecholamine metabolism in the cortex
Baksi, S. N., & Hughes, M. J. (1982) · Brain Research · doi:10.1016/0006-8993(82)90331-6 · Cited by 74
Parkinson’s disease and osteoporosis
Vaserman, N. (2004) · Joint Bone Spine · doi:10.1016/j.jbspin.2004.04.012 · Cited by 70
Grant, W. B., Garland, C. F., & Gorham, E. D. (2007) · Springer eBooks · doi:10.1007/978-3-540-37696-5_20 · Cited by 55
Whiting, S. J., Green, T., & Calvo, M. S. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.12.067 · Cited by 50
Cited by
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Role of ROS and Nutritional Antioxidants in Human Diseases
Liu, Z., Ren, Z., Zhang, J., Chuang, C.-C., Kandaswamy, E., Zhou, T., & Zuo, L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00477 · Cited by 860
Eyles, D. W., Burne, T. H. J., & McGrath, J. J. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.07.001 · Cited by 699
A comprehensive overview on osteoporosis and its risk factors
Pouresmaeili, F., Kamali Dehghan, B., Kamarehei, M., & Yong Meng, G. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s138000 · Cited by 597
Vitamin D and Risk of Cognitive Decline in Elderly Persons
Llewellyn, D. J. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.173 · Cited by 459
Metadata
- Authors
- Evatt, M. L., DeLong, M. R., Khazai, N., Rosen, A., Triche, S., & Tangpricha, V.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2008-10-01
- Volume
- 65
- Issue
- 10
- Pages
- 1348-52
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2149732522
- Cited by
- 378
- References
- 25
- FWCI
- 13.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.